ASH 2016 Annual Meeting Highlights in Hodgkin Lymphoma


Immunotherapy
Stephen M. Ansell, MD, PhD

Begin


Biomarkers
Bruce D. Cheson, MD, FACP, FAAS

Begin


PET-adapted Therapy
Martin Hutchings, MD, PhD

Begin


Anti-CD30 Therapy
Alison J. Moskowitz, MD

Begin

MediCom Worldwide, Inc. would like to recognize and thank Bristol-Myers Squibb, Merck & Co., Inc., and Seattle Genetics for their educational support. To better serve the needs of our audience, ManagingHodgkinLymphoma.com is now ManagingLymphoma.com

©2019 MediCom Worldwide, Inc. All rights reserved